Abstract
An effective system for drug monitoring is necessary in any developing country that assumes responsibility for the safety, quality, and efficacy of the medicines that are available to its people. This is achievable, given the following: 1. a national policy commitment to good standards of medicines, 2. a sound system of drug regulation that serves the principles of public integrity and accountability, and 3. government policy that respects intellectual property and the innovative nature of the pharmaceutical industry (including the generic industry).A proposed national plan for the conduct of drug monitoring in a developing country that requires the cooperation of government, industry, academia, the national drug regulatory authority, the medical and pharmacy professions, international nongovernment donor agencies, and the public will be described. It can be supported by a small proportion of the drug vote. Veterinary, homeopathic, dental and traditional medicines, medical devices, and blood products are ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
